Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease

Circulation

Volumn 100, Issue 16, 1999, Pages 1690-1696

  Webb, Carolyn M ^a   McNeill, John G ^a   Hayward, Christopher S ^a   De Zeigler, Dominique ^b   Collins, Peter ^a,c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Columbia Laboratories ^*  (France)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Blood flow; Coronary arteries; Testosterone

Indexed keywords

ACETYLCHOLINE; ALCOHOL; DRUG VEHICLE; ISOSORBIDE DINITRATE; TESTOSTERONE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HUMAN; INTRACORONARY INFUSION; MALE; PRIORITY JOURNAL; VASOMOTOR REFLEX;

EID: 0033584717     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.16.1690     Document Type: Article

References (27)

1. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
2. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994; 14:701-706.
3. Levine SA, Likoff WB. The therapeutic value of testosterone propionate in angina pectoris. N Engl J Med. 1943;229:770-772.
4. Lesser MA. Testosterone propionate therapy in one hundred cases of angina pectoris. J Clin Endocrinol. 1946;6:549-557.
5. Webb CM, Adamson DL, de Ziegler D, Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol. 1999;83:437-439.
6. Jaffe MD. Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J. 1977;39:1217-1222.
7. Yue P, Chatterjee K, Beale C, Poole-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91: 1154-1160.
8. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol. 1997;29:800-807.
9. Collins P, Rosano GMC, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill J, Poole-Wilson PA. Estradiol-17β attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995;92:24-30.
10. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85:1899-1911.
11. Vrolix MC, Sionis D, Piessens J, Van Lierde J, Willems JL, De Geest H. Changes in human coronary flow reserve after administration of intracoronary diltiazem. J Cardiovasc Pharmacol. 1991;18(suppl 9):S64-S67.
12. Haager PK, Klues HG, Schmidt M, vom Dahl J, Hanrath P. Effects of nitroglycerin and nicorandil on regional poststenotic quantitative coronary blood flow in coronary artery disease: a combined digital quantitative angiographic and intracoronary Doppler study. J Cardiovasc Pharmacol 1999;33:126-134.
13. Chou TM, Sudhir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614-2619.
14. McGill HC Jr, Sheridan PJ. Nuclear uptake of sex steroid hormones in the cardiovascular system of the baboon. Circ Res. 1981;48:238-244.
15. Lin AL, Gonzalez R Jr, Shain SA. Androgen directs apparent cytoplasmic and nuclear distribution of rat cardiovascular androgen receptors. Arteriosclerosis. 1985;5:659-667.
16. Higashiura K, Mathur RS, Halushka PV. Gender-related differences in androgen regulation of thromboxane A2 receptors in rat aortic smooth-muscle cells. J Cardiovasc Pharmacol. 1997;29:311-315.
17. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
18. Hassan T. A Guide to Medical Endocrinology. London: MacMillan; 1985.
19. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73: 1016-1025.
20. Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab. 1986;63: 1418-1420.
21. Harman SM, Tsitouras PD, Costa PT. Reproductive hormones in aging men, II: basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1982; 54:547-551.
22. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 1995;15: 562-570.
23. Thompson PD, Cullinane EM, Sady SP, Chenevert C, Saritelli AL, Sady MA, Herbert PN. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA. 1989;261:1165-1168.
24. Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation. 1995;91:2742-2747.
25. Heller RF, Meade TW, Haines AP, Stirling Y, Miller NE, Lewis B. Inter-relationships between factor VII, serum testosterone and plasma lipoproteins. Thromb Res. 1982;28:423-425.
26. Bagatell CJ, Bremner WJ. Androgens in men: uses and abuses. N Engl J Med. 1996;334:707-714.
27. Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res. 1999;84:813-819.